Margherita Rimini

机构：Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele · ORCID：0000-0002-4047-2585

发表论文 153 篇 · 总被引 2000 次 · h-index 24

代表论文

• Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
• A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index (2025 · Liver International · 被引 9)
• Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting (2025 · Targeted Oncology · 被引 8)
• Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study (2025 · Liver Cancer · 被引 5)
• Ivosidenib for IDH1‐Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real‐World Study (2025 · Liver International · 被引 4)
• Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population (2025 · International Journal of Cancer · 被引 4)